Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2020

Accounting Policies [Abstract]

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following common share equivalents were excluded from the computation of diluted net income (loss) per common share for the periods presented because including them would have been antidilutive (in thousands):

	Years Ended December 31,
	2020		2019
Stock options		16,215		15,060
Lineage Warrants (1) (Note 3)		1,090		1,090
Restricted stock units		93		166

⁽¹⁾ Although the Lineage Warrants are classified as liabilities, these warrants are considered for dilutive earnings per share calculations in accordance with ASC 260, Earnings Per Share, and determined to be anti-dilutive for the period presented.

Schedule of Reconciliation of Cash, Cash Equivalents, and Restricted Cash

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheet dates that comprise the total of the same such amounts shown in the condensed consolidated statements of cash flows for all periods presented herein (in thousands):

	December 31, 2020		December 31, 2019
Cash and cash equivalents	$	32,585	$	9,497
Restricted cash included in deposits and other long-term assets (see Note 14)		520		599
Restricted cash included in prepaid expenses and other current assets (see Note 14)		78		-
Total cash, cash equivalents, and restricted cash as shown in the condensed consolidated statements of cash flows	$	33,183	$	10,096

Schedule of Disaggregated Revenues

The following table presents Lineage’s consolidated revenues disaggregated by source (in thousands).

	Year Ended December 31,
	2020		2019
REVENUES:
Grant revenue	$	1,053	$	2,037
Royalties from product sales and license fees		773		1,221
Sale of research products and services		-		257
Total revenues	$	1,826	$	3,515

Schedule of Revenues Disaggregated by Geography

The following table presents consolidated revenues, disaggregated by geography, based on the billing addresses of customers, or in the case of grant revenues, based on where the governmental entities that fund the grant are located (in thousands).

	Year Ended December 31,
	2020		2019
REVENUES:
United States	$	1,160	$	2,092
Foreign (1)		666		1,423
Total revenues	$	1,826	$	3,515

(1) Foreign revenues are primarily generated from grants in Israel.